.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Deloitte
Argus Health
Colorcon
Dow
QuintilesIMS
Cipla
Baxter
Covington

Generated: July 26, 2017

DrugPatentWatch Database Preview

Candesartan cilexetil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for candesartan cilexetil and what is the scope of candesartan cilexetil patent protection?

Candesartan cilexetil
is the generic ingredient in four branded drugs marketed by Sandoz, Macleods Pharms Ltd, Alembic Pharms Ltd, Astrazeneca, Apotex Inc, Mylan Pharms Inc, and Dr Reddys Labs Ltd, and is included in ten NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for candesartan cilexetil. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: candesartan cilexetil

Tradenames:4
Patents:1
Applicants:7
NDAs:10
Drug Master File Entries: see list22
Suppliers / Packagers: see list13
Bulk Api Vendors: see list72
Clinical Trials: see list133
Patent Applications: see list3,207
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:candesartan cilexetil at DailyMed

Pharmacology for Ingredient: candesartan cilexetil

Tentative approvals for CANDESARTAN CILEXETIL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe16MG; 12.5MGTABLET; ORAL
► Subscribe► Subscribe32MG; 25MGTABLET; ORAL
► Subscribe► Subscribe32MG; 12.5MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL202965-003Jun 3, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL203813-003Dec 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL204100-003Feb 27, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL203813-001Dec 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: candesartan cilexetil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-001Jun 4, 1998► Subscribe► Subscribe
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-003Jun 4, 1998► Subscribe► Subscribe
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-004Jun 4, 1998► Subscribe► Subscribe
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-004Jun 4, 1998► Subscribe► Subscribe
Astrazeneca
ATACAND
candesartan cilexetil
TABLET;ORAL020838-002Jun 4, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Moodys
Boehringer Ingelheim
Dow
Farmers Insurance
McKinsey
Fuji
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot